# Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease

> **NCT07658807** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 300 (estimated)

## Conditions studied

- Peripheral Arterial Disease
- Diabetic Angiopathies
- Arterial Occlusive Diseases

## Interventions

- **DRUG:** Hua Yu Wan Capsule
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT07658807
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-02
- **Final completion:** 2029-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658807, "Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07658807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*